BIOCRYST PHARMACEUTICALS, INC. Gain (Loss) on Foreign Currency Derivative Instruments Not Designated as Hedging Instruments
BIOCRYST PHARMACEUTICALS, INC. (BCRX) reported Gain (Loss) on Foreign Currency Derivative Instruments Not Designated as Hedging Instruments of $27.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Other Income
us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments · last filed 2026-08-05
- BIOCRYST PHARMACEUTICALS, INC. gain (loss) on foreign currency derivative instruments not designated as hedging instruments for the quarter ending 2026-06-30 was $27.00K.
- BIOCRYST PHARMACEUTICALS, INC. gain (loss) on foreign currency derivative instruments not designated as hedging instruments for the quarter ending 2026-03-31 was -$225.00K, a 22600.00% decline year-over-year.
- BIOCRYST PHARMACEUTICALS, INC. gain (loss) on foreign currency derivative instruments not designated as hedging instruments for the quarter ending 2025-12-31 was -$125.00K.
- BIOCRYST PHARMACEUTICALS, INC. gain (loss) on foreign currency derivative instruments not designated as hedging instruments for the quarter ending 2025-09-30 was $35.00K, a 64.29% decline year-over-year.
- BIOCRYST PHARMACEUTICALS, INC. gain (loss) on foreign currency derivative instruments not designated as hedging instruments for fiscal 2025 was -$152.00K.
- BIOCRYST PHARMACEUTICALS, INC. gain (loss) on foreign currency derivative instruments not designated as hedging instruments for fiscal 2024 was -$641.00K.
- BIOCRYST PHARMACEUTICALS, INC. gain (loss) on foreign currency derivative instruments not designated as hedging instruments for fiscal 2023 was -$1.04M.
- BIOCRYST PHARMACEUTICALS, INC. gain (loss) on foreign currency derivative instruments not designated as hedging instruments for fiscal 2022 was -$1.98M.
| Period end | Gain (Loss) on Foreign Currency Derivative Instruments Not Designated as Hedging Instruments 3 month | Gain (Loss) on Foreign Currency Derivative Instruments Not Designated as Hedging Instruments 6 month | Gain (Loss) on Foreign Currency Derivative Instruments Not Designated as Hedging Instruments 9 month | Gain (Loss) on Foreign Currency Derivative Instruments Not Designated as Hedging Instruments 12 month |
|---|---|---|---|---|
| 2026-06-30 | $27.00K 10-Q · filed 2026-08-05 | -$198.00K 10-Q · filed 2026-08-05 | -$323.00K derived: sum of 3 quarters · filed 2026-08-05 | -$288.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | -$225.00K 10-Q · filed 2026-05-06 | -$350.00K derived: sum of 2 quarters · filed 2026-05-06 | -$315.00K derived: sum of 3 quarters · filed 2026-05-06 | -$378.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | -$125.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$90.00K derived: sum of 2 quarters · filed 2026-02-26 | -$153.00K derived: sum of 3 quarters · filed 2026-08-05 | -$152.00K 10-K · filed 2026-02-26 |
| 2025-09-30 | $35.00K 10-Q · filed 2025-11-04 | -$28.00K derived: sum of 2 quarters · filed 2026-08-05 | -$27.00K 10-Q · filed 2025-11-04 | -$631.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | -$63.00K 10-Q · filed 2026-08-05 | -$62.00K 10-Q · filed 2026-08-05 | -$666.00K derived: sum of 3 quarters · filed 2026-08-05 | -$568.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $1.00K 10-Q · filed 2026-05-06 | -$603.00K derived: sum of 2 quarters · filed 2026-05-06 | -$505.00K derived: sum of 3 quarters · filed 2026-05-06 | -$589.00K derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | -$604.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$506.00K derived: sum of 2 quarters · filed 2026-02-26 | -$590.00K derived: sum of 3 quarters · filed 2026-02-26 | -$641.00K 10-K · filed 2026-02-26 |
| 2024-09-30 | $98.00K 10-Q · filed 2025-11-04 | $14.00K derived: sum of 2 quarters · filed 2025-11-04 | -$37.00K 10-Q · filed 2025-11-04 | -$411.00K derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | -$84.00K 10-Q · filed 2025-08-05 | -$135.00K 10-Q · filed 2025-08-05 | -$509.00K derived: sum of 3 quarters · filed 2026-02-26 | -$1.25M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | -$51.00K 10-Q · filed 2025-05-06 | -$425.00K derived: sum of 2 quarters · filed 2026-02-26 | -$1.16M derived: sum of 3 quarters · filed 2026-02-26 | -$861.00K derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | -$374.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$1.11M derived: sum of 2 quarters · filed 2026-02-26 | -$810.00K derived: sum of 3 quarters · filed 2026-02-26 | -$1.04M 10-K · filed 2026-02-26 |
| 2023-09-30 | -$737.00K 10-Q · filed 2024-11-05 | -$436.00K derived: sum of 2 quarters · filed 2024-11-05 | -$665.00K 10-Q · filed 2024-11-05 | -$2.06M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-06-30 | $301.00K 10-Q · filed 2024-08-06 | $72.00K 10-Q · filed 2024-08-06 | -$1.33M derived: sum of 3 quarters · filed 2025-02-25 | -$1.87M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-03-31 | -$229.00K 10-Q · filed 2024-05-07 | -$1.63M derived: sum of 2 quarters · filed 2025-02-25 | -$2.17M derived: sum of 3 quarters · filed 2025-02-25 | -$2.04M derived: sum of 4 quarters · filed 2025-02-25 |
| 2022-12-31 | -$1.40M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | -$1.94M derived: sum of 2 quarters · filed 2025-02-25 | -$1.81M derived: sum of 3 quarters · filed 2025-02-25 | -$1.98M 10-K · filed 2025-02-25 |
| 2022-09-30 | -$538.00K 10-Q · filed 2023-11-08 | -$406.00K derived: sum of 2 quarters · filed 2023-11-08 | -$583.00K 10-Q · filed 2023-11-08 | -$1.00M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-06-30 | $132.00K 10-Q · filed 2023-08-07 | -$45.00K 10-Q · filed 2023-08-07 | -$466.00K derived: sum of 3 quarters · filed 2024-02-27 | -$577.00K derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-03-31 | -$177.00K 10-Q · filed 2023-05-08 | -$598.00K derived: sum of 2 quarters · filed 2024-02-27 | -$709.00K derived: sum of 3 quarters · filed 2024-02-27 | -$843.00K derived: sum of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | -$421.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | -$532.00K derived: sum of 2 quarters · filed 2024-02-27 | -$666.00K derived: sum of 3 quarters · filed 2024-02-27 | -$695.00K 10-K · filed 2024-02-27 |
| 2021-09-30 | -$111.00K 10-Q · filed 2022-11-04 | -$245.00K derived: sum of 2 quarters · filed 2022-11-04 | -$274.00K 10-Q · filed 2022-11-04 | -$1.27M derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-06-30 | -$134.00K 10-Q · filed 2022-08-05 | -$163.00K 10-Q · filed 2022-08-05 | -$1.16M derived: sum of 3 quarters · filed 2023-02-27 | -$1.17M derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-03-31 | -$29.00K 10-Q · filed 2022-05-09 | -$1.02M derived: sum of 2 quarters · filed 2023-02-27 | -$1.04M derived: sum of 3 quarters · filed 2023-02-27 | -$974.00K derived: sum of 4 quarters · filed 2023-02-27 |
| 2020-12-31 | -$996.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | -$1.01M derived: sum of 2 quarters · filed 2023-02-27 | -$945.00K derived: sum of 3 quarters · filed 2023-02-27 | -$965.00K 10-K · filed 2023-02-27 |
| 2020-09-30 | -$12.00K 10-Q · filed 2021-11-04 | $51.00K derived: sum of 2 quarters · filed 2021-11-04 | $31.00K 10-Q · filed 2021-11-04 | $217.00K derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | $63.00K 10-Q · filed 2021-08-09 | $43.00K 10-Q · filed 2021-08-09 | $229.00K derived: sum of 3 quarters · filed 2022-02-28 | $377.00K derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | -$20.00K 10-Q · filed 2021-05-07 | $166.00K derived: sum of 2 quarters · filed 2022-02-28 | $314.00K derived: sum of 3 quarters · filed 2022-02-28 | $91.00K derived: sum of 4 quarters · filed 2022-02-28 |
| 2019-12-31 | $186.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $334.00K derived: sum of 2 quarters · filed 2022-02-28 | $111.00K derived: sum of 3 quarters · filed 2022-02-28 | $517.00K 10-K · filed 2022-02-28 |
| 2019-09-30 | $148.00K 10-Q · filed 2020-11-06 | -$75.00K derived: sum of 2 quarters · filed 2020-11-06 | $331.00K 10-Q · filed 2020-11-06 | -$111.00K derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-06-30 | -$223.00K 10-Q · filed 2020-08-07 | $183.00K 10-Q · filed 2020-08-07 | -$259.00K derived: sum of 3 quarters · filed 2021-03-01 | $372.00K derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-03-31 | $406.00K 10-Q · filed 2020-05-11 | -$36.00K derived: sum of 2 quarters · filed 2021-03-01 | $595.00K derived: sum of 3 quarters · filed 2021-03-01 | $2.10M derived: sum of 4 quarters · filed 2021-03-01 |
| 2018-12-31 | -$442.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $189.00K derived: sum of 2 quarters · filed 2021-03-01 | $1.70M derived: sum of 3 quarters · filed 2021-03-01 | -$108.00K 10-K · filed 2021-03-01 |
| 2018-09-30 | $631.00K 10-Q · filed 2019-11-08 | $2.14M derived: sum of 2 quarters · filed 2019-11-08 | $334.00K 10-Q · filed 2019-11-08 | $405.00K derived: sum of 4 quarters · filed 2020-03-13 |
| 2018-06-30 | $1.51M 10-Q · filed 2019-08-08 | -$297.00K 10-Q · filed 2019-08-08 | -$226.00K derived: sum of 3 quarters · filed 2020-03-13 | -$96.00K derived: sum of 4 quarters · filed 2020-03-13 |
| 2018-03-31 | -$1.80M 10-Q · filed 2019-05-09 | -$1.73M derived: sum of 2 quarters · filed 2020-03-13 | -$1.60M derived: sum of 3 quarters · filed 2020-03-13 | -$1.08M derived: sum of 4 quarters · filed 2020-03-13 |
| 2017-12-31 | $71.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | $201.00K derived: sum of 2 quarters · filed 2020-03-13 | $722.00K derived: sum of 3 quarters · filed 2020-03-13 | -$821.00K 10-K · filed 2020-03-13 |
| 2017-09-30 | $130.00K 10-Q · filed 2018-11-08 | $651.00K derived: sum of 2 quarters · filed 2018-11-08 | -$892.00K 10-Q · filed 2018-11-08 | $4.83M derived: sum of 4 quarters · filed 2019-03-14 |
| 2017-06-30 | $521.00K 10-Q · filed 2018-08-09 | -$1.02M 10-Q · filed 2018-08-09 | $4.70M derived: sum of 3 quarters · filed 2019-03-14 | $3.77M derived: sum of 4 quarters · filed 2019-03-14 |
| 2017-03-31 | -$1.54M 10-Q · filed 2018-05-09 | $4.17M derived: sum of 2 quarters · filed 2019-03-14 | $3.24M derived: sum of 3 quarters · filed 2019-03-14 | $367.00K derived: sum of 4 quarters · filed 2019-03-14 |
| 2016-12-31 | $5.72M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | $4.79M derived: sum of 2 quarters · filed 2019-03-14 | $1.91M derived: sum of 3 quarters · filed 2019-03-14 | -$843.00K 10-K · filed 2019-03-14 |
| 2016-09-30 | -$931.00K 10-Q · filed 2017-11-08 | -$3.81M derived: sum of 2 quarters · filed 2017-11-08 | -$6.56M 10-Q · filed 2017-11-08 | -$6.33M derived: sum of 4 quarters · filed 2018-03-12 |
| 2016-06-30 | -$2.88M 10-Q · filed 2017-08-08 | -$5.63M 10-Q · filed 2017-08-08 | -$5.40M derived: sum of 3 quarters · filed 2018-03-12 | -$5.75M derived: sum of 4 quarters · filed 2018-03-12 |
| 2016-03-31 | -$2.75M 10-Q · filed 2017-05-08 | -$2.52M derived: sum of 2 quarters · filed 2018-03-12 | -$2.88M derived: sum of 3 quarters · filed 2018-03-12 | -$2.13M derived: sum of 4 quarters · filed 2018-03-12 |
| 2015-12-31 | $229.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12 | -$123.00K derived: sum of 2 quarters · filed 2018-03-12 | $626.00K derived: sum of 3 quarters · filed 2018-03-12 | $1.09M 10-K · filed 2018-03-12 |
| 2015-09-30 | -$352.00K 10-Q · filed 2016-11-08 | $397.00K derived: sum of 2 quarters · filed 2016-11-08 | $861.00K 10-Q · filed 2016-11-08 | $5.62M derived: sum of 4 quarters · filed 2017-02-27 |
| 2015-06-30 | $749.00K 10-Q · filed 2016-08-08 | $1.21M 10-Q · filed 2016-08-08 | $5.97M derived: sum of 3 quarters · filed 2017-02-27 | $10.05M derived: sum of 4 quarters · filed 2017-02-27 |
| 2015-03-31 | $464.00K 10-Q · filed 2016-05-09 | $5.22M derived: sum of 2 quarters · filed 2017-02-27 | $9.30M derived: sum of 3 quarters · filed 2017-02-27 | $7.48M derived: sum of 4 quarters · filed 2017-02-27 |
| 2014-12-31 | $4.75M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | $8.84M derived: sum of 2 quarters · filed 2017-02-27 | $7.01M derived: sum of 3 quarters · filed 2017-02-27 | $5.49M 10-K · filed 2017-02-27 |
| 2014-09-30 | $4.08M 10-Q · filed 2015-11-06 | $2.26M derived: sum of 2 quarters · filed 2015-11-06 | $732.00K 10-Q · filed 2015-11-06 | $2.86M derived: sum of 4 quarters · filed 2016-02-26 |
| 2014-06-30 | -$1.82M 10-Q · filed 2015-08-07 | -$3.35M 10-Q · filed 2015-08-07 | -$1.22M derived: sum of 3 quarters · filed 2016-02-26 | -$1.13M derived: sum of 4 quarters · filed 2016-02-26 |
| 2014-03-31 | -$1.53M 10-Q · filed 2015-05-08 | $600.00K derived: sum of 2 quarters · filed 2016-02-26 | $697.00K derived: sum of 3 quarters · filed 2016-02-26 | $1.81M derived: sum of 4 quarters · filed 2016-02-26 |
| 2013-12-31 | $2.13M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | $2.22M derived: sum of 2 quarters · filed 2016-02-26 | $3.34M derived: sum of 3 quarters · filed 2016-02-26 | $5.29M 10-K · filed 2016-02-26 |
| 2013-09-30 | $97.00K 10-Q · filed 2014-11-07 | $1.21M derived: sum of 2 quarters · filed 2014-11-07 | $3.17M 10-Q · filed 2014-11-07 | $3.95M derived: sum of 4 quarters · filed 2015-03-02 |
| 2013-06-30 | $1.11M 10-Q · filed 2014-08-08 | $3.07M 10-Q · filed 2014-08-08 | $3.85M derived: sum of 3 quarters · filed 2015-03-02 | $3.28M derived: sum of 4 quarters · filed 2015-03-02 |
| 2013-03-31 | $1.96M 10-Q · filed 2014-05-09 | $2.74M derived: sum of 2 quarters · filed 2015-03-02 | $2.17M derived: sum of 3 quarters · filed 2015-03-02 | $1.17M derived: sum of 4 quarters · filed 2015-03-02 |
| 2012-12-31 | $782.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | $210.00K derived: sum of 2 quarters · filed 2015-03-02 | -$787.00K derived: sum of 3 quarters · filed 2015-03-02 | -$749.00K 10-K · filed 2015-03-02 |
| 2012-09-30 | -$572.00K 10-Q · filed 2013-11-08 | -$1.57M derived: sum of 2 quarters · filed 2013-11-08 | -$1.53M 10-Q · filed 2013-11-08 | -$2.60M derived: sum of 4 quarters · filed 2014-03-10 |
| 2012-06-30 | -$997.00K 10-Q · filed 2013-08-08 | -$959.00K 10-Q · filed 2013-08-08 | -$2.03M derived: sum of 3 quarters · filed 2014-03-10 | -$2.62M derived: sum of 4 quarters · filed 2014-03-10 |
| 2012-03-31 | $38.00K 10-Q · filed 2013-05-09 | -$1.04M derived: sum of 2 quarters · filed 2014-03-10 | -$1.62M derived: sum of 3 quarters · filed 2014-03-10 | -$2.62M derived: sum of 4 quarters · filed 2014-03-10 |
| 2011-12-31 | -$1.07M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-10 | -$1.66M derived: sum of 2 quarters · filed 2014-03-10 | -$2.66M derived: sum of 3 quarters · filed 2014-03-10 | -$4.00M 10-K · filed 2014-03-10 |
| 2011-09-30 | -$586.00K 10-Q · filed 2012-11-08 | -$1.58M derived: sum of 2 quarters · filed 2012-11-08 | -$2.93M 10-Q · filed 2012-11-08 | |
| 2011-06-30 | -$998.00K 10-Q · filed 2012-08-08 | -$2.34M 10-Q · filed 2012-08-08 | ||
| 2011-03-31 | -$1.34M 10-Q · filed 2012-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |